Dr Stefanie Fischer speaks to ecancer at the 2019 ASCO Genitourinary Cancers Symposium about a retrospective analysis looking at outcomes of clinical stage I nonseminoma patients who relapse after adjuvant chemotherapy with BEP.

She reports that a high rate of late and subsequent relapses was seen, with 29% occurring more than 3 years after adjuvant treatment and one even 25 years after.

Prof Fischer explains that they used a negative selection and only focused on those who relapsed, so this analysis does not affect the general very good outcome seen from adjuvant BEP.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

свернуть